S C R U B B I N G U P
Sabyasachi Ghosh , Associate Vice President at Future Market Insights
Although this technology does have the potential to put surgeons at ease during potentially challenging procedures , it has also greatly reduced human error opportunities through enhanced accuracy .
Highly controlled precision placement means that catheters get in just where they need to be , resulting in fewer complications and increased chances of success . Moreover , robotic systems reduce dependence on manual adjustments that , among other things , may contribute to error or duplication of technique .
Besides better control over precision , robotic systems minimise radiation exposure , a frequent concern in conventional catheterisation procedures . By offering better control of the whole procedure , in conjunction with real-time imaging , the amount of fluoroscopy required is reduced , consequently cutting the radiation dose for patients . Such benefits , therefore , translate into safer procedures , which consequently lessen the risk of side effects related to radiation exposure .
Reducing radiation risks and enhancing precision will create opportunities in the market
The opportunistic approach to this market is driven by the factor of reduced risk in terms of occupational hazards with reference to radiation exposure for cardiologists . During the interventional cardiology procedures , it has been reported by majority of surgeons that the occupational hazards associated with interventional cardiology procedures affected them .
The modern cath labs use ionising radiation comprehensively in the form of X-rays , which is responsible for the practitioners to be exposed to risk of malignancy also comprising the neck and head region .
Though the preventive measures , such as the utilisation of lead aprons may reduce the impact of such risk associated factors , it is to be noted that their long term use may be associated with the development of orthopaedic injuries among practitioners .
The market for robotic catheterisation systems is thus set to witness a lucrative growth with the advancement in technology as well as the extensive testing of these systems in clinical trials for their efficacy .
Challenges in adopting robotic catheterisation systems for peripheral vascular interventions
The restricted mechanical capacity of balloon angioplasty in peripheral vascular interventions to recover calcified lesions has given rise to the development of novel technologies using robot assisted catheterisation procedures . Conventionally , large number of robot-assisted catheterisation technologies have been established to assist with the physicians ’ ability to operate with percutaneous coronary intervention procedures .
However , there lacks data comparing the endovascular options and thus , there is large parity with regard to establishing which robot assisted catheterisation procedure would benefit the patient , depending upon the disease and procedural impact on surgical outcomes .
Additionally , the high upfront cost of robotic catheterisation systems depicts a negative impact on the end users ’ decision to purchase them . Setting robot-assisted endovascular procedures as standard of care may take time since special reimbursement for robotic assisted catheterisation are not available .
The lack of studies demonstrating cost effectiveness and outcome data from manufacturers might make it challenging for care centres to justify investing in the robotic platform . By extending the spectrum of indications for robotic catheterised procedures , manufacturers may improve their applicability and potentially gain market share in the long term .
Other major complications include infection at the insertion site of the robotic catheterisation systems guiding wire and catheter , contamination of the burr catheter and seeding of the catheter .
Regional insights
United States dominates market : Driven by aging population and technological innovation
The United States has a stronghold in the North American market for robotic catheterisation systems in 2024 , and growth is expected throughout the forecast period .
68 www . intelligenthealth . tech